Your browser doesn't support javascript.
loading
Efficacy and safety of pembrolizumab for treating advanced non-small-cell lung cancer: a meta-analysis of phase II and III randomized controlled trials.
Gong, Tianyao; Liu, Lei; Liu, Yufei; Liu, Ke; Yang, Yang; Li, Liuying; Zhang, Chuantao.
Afiliação
  • Gong T; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Liu L; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Liu Y; Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Liu K; Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Yang Y; Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Li L; Department of Integrated Chinese and Western Medicine, The First People's Hospital of Zigong City, Zigong, Sichuan, China.
  • Zhang C; Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
J Chemother ; 34(7): 427-435, 2022 Nov.
Article em En | MEDLINE | ID: mdl-34895095

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article